Hyperkalemia: Difference between revisions
GregArmani (talk | contribs) No edit summary |
ClaireLewis (talk | contribs) No edit summary |
||
(47 intermediate revisions by 15 users not shown) | |||
Line 1: | Line 1: | ||
== Background == | ==Background== | ||
*Defined as > | *Defined as >5.5 mEq/L | ||
*Consider pseudohyperkalemia (e.g. from hemolysis) | *Consider pseudohyperkalemia (e.g. from hemolysis) | ||
*Potassium secretion is proportional to flow rate and sodium delivery through distal nephron | *Potassium secretion is proportional to flow rate and sodium delivery through distal nephron | ||
**Thus, loop & thiazide diuretics cause ''hypo''kalmia | **Thus, loop & thiazide [[diuretics]] cause ''hypo''kalmia | ||
===Medication Causes=== | ===Medication Causes=== | ||
====Alter transmembrane potassium movement==== | ====Alter transmembrane potassium movement==== | ||
*β blockers | *[[β blockers]] | ||
*Digoxin | *[[Digoxin]] | ||
*Potassium-containing drugs | *Potassium-containing drugs | ||
*Potassium supplements | *Potassium supplements | ||
*Salt substitutes | *Salt substitutes | ||
*Hyperosmolar solutions (mannitol, glucose) | *Hyperosmolar solutions ([[mannitol]], [[dextrose|glucose]]) | ||
*Suxamethonium | *Suxamethonium | ||
*Intravenous cationic amino acids | *Intravenous cationic amino acids | ||
*Stored red blood cells (haemolysis releases potassium) | *Stored [[pRBCs|red blood cells]] (haemolysis releases potassium) | ||
*Herbal medicines (such as alfalfa, dandelion, horsetail, milkweed, and nettle) | *Herbal medicines (such as alfalfa, dandelion, horsetail, milkweed, and nettle) | ||
====Reduce aldosterone secretion==== | ====Reduce aldosterone secretion==== | ||
*ACE inhibitors; Angiotensin II receptor blockers | *[[ACE inhibitors]]; [[Angiotensin II receptor blockers]] | ||
*NSAIDs | *[[NSAIDs]] | ||
* | *[[Heparin]] | ||
*Antifungals (ketoconazole, fluconazole, itraconazole) | *[[Antifungals]] ([[ketoconazole]], [[fluconazole]], [[itraconazole]]) | ||
* | *[[Cyclosporine]] | ||
*Tacrolimus | *[[Tacrolimus]] | ||
====Block aldosterone binding to mineralocorticoid receptors==== | ====Block aldosterone binding to mineralocorticoid receptors==== | ||
*Spironolactone | *[[Spironolactone]] | ||
*Eplerenone | *[[Eplerenone]] | ||
*Drospirenone | *[[Drospirenone]] | ||
*Potassium sparing diuretics (amiloride, triamterene) | *Potassium sparing [[diuretics]] (amiloride, triamterene) | ||
*Trimethoprim | *[[Trimethoprim]] | ||
*Pentamidine | *[[Pentamidine]] | ||
==Clinical Features== | ==Clinical Features== | ||
''Typically non-specific'' | |||
*[[Muscle weakness]] | |||
*[[Lethargy]], [[fatigue]] | |||
*[[Paresthesias]] | |||
*[[Nausea and Vomiting]] | |||
*[[Difficulty breathing]] | |||
*[[Palpitations]], [[chest pain]] | |||
== Differential Diagnosis == | ==Differential Diagnosis== | ||
{{Hyperkalemia DDX}} | |||
{{Peaked T-waves DDX}} | |||
{{Tachycardia (wide) DDX}} | |||
== | ==Evaluation== | ||
=== [[ECG]] | ===[[ECG]]=== | ||
''Changes NOT always predictable and sequential'' | ''Changes NOT always predictable and sequential'' | ||
*6.5 - 7.5 mEq/L: peaked T waves, prolonged PR interval, shortened QT interval | *6.5 - 7.5 mEq/L: peaked T waves, prolonged PR interval, shortened QT interval | ||
Line 54: | Line 55: | ||
*10 - 12 mEq/L: sine wave, ventricular fibrillation, heart block | *10 - 12 mEq/L: sine wave, ventricular fibrillation, heart block | ||
== | ==Management== | ||
===Stabilize cardiac membranes=== | ===Stabilize cardiac membranes=== | ||
''Indicated if there are any ECG changes or evidence of arrhythmias. Consider if K >7 mEq/L'' | ''Indicated if there are any ECG changes or evidence of arrhythmias. Consider if K >7 mEq/L'' | ||
Line 65: | Line 66: | ||
***Extravasation is bad: use a good IV | ***Extravasation is bad: use a good IV | ||
***Usually given in code situations | ***Usually given in code situations | ||
*Takes effect in 15-30 minutes<ref>http://lifeinthefastlane.com/hyperkalemia/. Accessed 02/22/2016</ref> | |||
**(If given for hyperkalemic cardiac arrest, need to continue resuscitation for at least 30 minutes) | |||
*Duration of action: 30 - 60 minutes <ref> The Effect of Calcium on Severe Hyperkalemia http://hqmeded-ecg.blogspot.com/2015/04/the-effect-of-calcium-on-severe.html</ref> | *Duration of action: 30 - 60 minutes <ref> The Effect of Calcium on Severe Hyperkalemia http://hqmeded-ecg.blogspot.com/2015/04/the-effect-of-calcium-on-severe.html</ref> | ||
*Use caution in patients taking [[Digitalis Toxicity|Digoxin]] although risk of [[Stone | *Use caution in patients taking [[Digitalis Toxicity|Digoxin]] although risk of [[Stone heart]] may be unsubstantiated <ref>Erickson CP, Olson KR. Case files of the medical toxicology fellowship of the California poison control system-San Francisco: calcium plus digoxin-more taboo than toxic? J Med Toxicol. 2008 Mar;4(1):33-9</ref> | ||
*Do serial [[ | *Do serial [[ECG]]s to track progress: may need to give multiple doses | ||
===Shift K+ intracellularly=== | ===Shift K+ intracellularly=== | ||
*Intravenous insulin + dextrose | *Intravenous [[insulin]] + [[dextrose]] | ||
**Give 10 units regular insulin intravenously with 25 to 50 grams (1 - 2 50 mL ampules) of 50% dextrose (D50) | **Give 10 units regular insulin intravenously with 25 to 50 grams (1 - 2 50 mL ampules) of 50% dextrose (D50) | ||
***May withhold dextrose if blood sugar > | ***May withhold dextrose if blood sugar >300mg/dl (>17 mmol/L) | ||
***Duration of effect: 4 - 6 hours | ***Duration of effect: 4 - 6 hours | ||
***Consider mixing in 10 cc NS syringe to ensure small volume of 10 units insulin fully administered via IV | ***Consider mixing in 10 cc NS syringe to ensure small volume of 10 units insulin fully administered via IV | ||
*Nebulized albuterol | ***Insulin cleared renally, be careful about inducing hypoglycemia (ESRD patients). | ||
****In a [https://onlinelibrary.wiley.com/doi/abs/10.1002/phar.2038 small 2017 retrospective cohort study], researchers found that giving 5 units of insulin instead of 10 units reduced serum potassium to the same extent as 10 units, with a lower rate of hypoglycemia. | |||
****Consider decreasing to 5 units or increasing dextrose dose to 50g with following risk factors: pretreatment blood glucose <150, acute kidney injury/chronic kidney disease, no history of DM, weight <60kg, female sex <ref> Moussavi K1, Fitter S2, Gabrielson SW3, Koyfman A4, Long B5. Management of Hyperkalemia With Insulin and Glucose: Pearls for the Emergency Clinician. J Emerg Med. 2019 Jul;57(1):36-42. </ref> | |||
*Nebulized [[albuterol]] 15 - 20mg | |||
**Response is dose-dependent | **Response is dose-dependent | ||
**Peak effect: 30 minutes | **Peak effect: 30 minutes | ||
**Duration of effect: 2 hours | **Duration of effect: 2 hours | ||
*Intravenous sodium bicarbonate | *Intravenous [[sodium bicarbonate]] 50ml of 8.4% solution (1 ampoule) given over 5 minutes | ||
**Duration of effect: 1 - 2 hours | **Duration of effect: 1 - 2 hours | ||
**Generally not required, unless pH <7.1 | **Generally not required, unless pH <7.1 | ||
===Remove K+ from | ===Remove K+ from body=== | ||
*Intravenous furosemide (Lasix) 40 - | *Intravenous [[furosemide]] (Lasix) 40 - 80mg | ||
**Ensure adequate urine output first | **Ensure adequate urine output first | ||
*[[Sodium polystyrene sulfonate]] ( | *[[Sodium polystyrene sulfonate]] (Kayexalate): 30 gm oral or per rectum | ||
**'''Very Controversial, High Risk of Bowel Perforation''', see: [[EBQ: Use of Kayexylate in Hyperkalemia]] | **'''Very Controversial, High Risk of Bowel Perforation''', see: [[EBQ: Use of Kayexylate in Hyperkalemia]] | ||
*Intravenous | *[[Sodium zirconium cyclosilicate]] | ||
*Definitive treatment is hemodialysis | **Potassium binder, similar to Kayexalate | ||
*Intravenous lactated ringers solution for volume expansion if dehydrated, rhabdomyolysis, diabetic ketoacidosis or other acidosis (avoid NS, causes hyperchloremic acidosis which shifts potassium out of cells increasing level) | |||
**consider isotonic bicarbonate if significant acidosis (D5W with 3 amps of bicarb per liter), can calculate bicarbonate deficit then divide by 150mEq/L to estimate number of liters of isotonic bicarbonate required) <ref> https://emcrit.org/pulmcrit/fluid-selection-using-ph-guided-resuscitation </ref> | |||
*[[Hydrocortisone]] if suspicious for [[adrenal insufficiency]] | |||
*Definitive treatment is [[hemodialysis]] | |||
== See Also == | ==Disposition== | ||
*[[Electrolyte | *Consideration for ICU for frequent electrolyte checks and close cardiac monitoring | ||
*[[Acute | |||
*[[Crush | ==See Also== | ||
*[[Electrolyte abnormalities]] | |||
*[[Acute kidney injury]] | |||
*[[Hemodialysis/Hemoperfusion]] | |||
*[[Crush syndrome]] | |||
==External Links== | ==External Links== | ||
*[https://ecgweekly.com/2015/01/case-of-the-week-january-12-2015/ ECG Weekly -Hyperkalemia] | *[https://ecgweekly.com/2015/01/case-of-the-week-january-12-2015/ ECG Weekly -Hyperkalemia] | ||
==References == | ==References== | ||
<references/> | <references/> | ||
[[Category:FEN]] | [[Category:FEN]] | ||
[[Category: | [[Category:Renal]] |
Revision as of 16:59, 16 October 2019
Background
- Defined as >5.5 mEq/L
- Consider pseudohyperkalemia (e.g. from hemolysis)
- Potassium secretion is proportional to flow rate and sodium delivery through distal nephron
- Thus, loop & thiazide diuretics cause hypokalmia
Medication Causes
Alter transmembrane potassium movement
- β blockers
- Digoxin
- Potassium-containing drugs
- Potassium supplements
- Salt substitutes
- Hyperosmolar solutions (mannitol, glucose)
- Suxamethonium
- Intravenous cationic amino acids
- Stored red blood cells (haemolysis releases potassium)
- Herbal medicines (such as alfalfa, dandelion, horsetail, milkweed, and nettle)
Reduce aldosterone secretion
- ACE inhibitors; Angiotensin II receptor blockers
- NSAIDs
- Heparin
- Antifungals (ketoconazole, fluconazole, itraconazole)
- Cyclosporine
- Tacrolimus
Block aldosterone binding to mineralocorticoid receptors
- Spironolactone
- Eplerenone
- Drospirenone
- Potassium sparing diuretics (amiloride, triamterene)
- Trimethoprim
- Pentamidine
Clinical Features
Typically non-specific
- Muscle weakness
- Lethargy, fatigue
- Paresthesias
- Nausea and Vomiting
- Difficulty breathing
- Palpitations, chest pain
Differential Diagnosis
Hyperkalemia
- Pseudohyperkalemia: hemolyzed specimen, prolonged tourniquet use prior to blood draw, thrombocytosis or leukocytosis
- Redistribution (shift from intracellular to extracellular space)
- Acidemia (see DKA)
- Cellular breakdown: see Rhabdomyolysis/Crush syndrome, electrical/thermal burn, hemolysis, see Tumor lysis syndrome
- Increased total body potassium
- Inadequate excretion: Acute/chronic renal failure, Addison's disease, type 4 RTA
- Drug-induced: potassium-sparing diuretic (spironolactone), angiotensin converting enzyme inhibitors (ACE-I), nonsteroidal anti-inflammatory drugs (NSAIDs)
- Excessive intake: diet, blood transfusion
- Other causes: succinylcholine, digitalis, beta-blockers
Peaked T-waves
- MI (hyperacute T waves)
- Hyperkalemia
- Benign Early Repolarization
- De Winter's T waves (acute LAD occlusion)
Wide-complex tachycardia
Assume any wide-complex tachycardia is ventricular tachycardia until proven otherwise (it is safer to incorrectly assume a ventricular dysrhythmia than supraventricular tachycardia with abberancy)
- Regular
- Monomorphic ventricular tachycardia
- PSVT with aberrant conduction:
- PSVT with bundle branch block^
- PSVT with accessory pathway
- Atrial flutter with bundle branch block^
- Sinus tachycardia with bundle branch block^
- Accelerated idioventricular rhythm (consider if less than or ~120 bpm)
- Metabolic
- Irregular
- Atrial fibrillation/atrial flutter with variable AV conduction AND bundle branch block^
- Atrial fibrillation/atrial flutter with variable AV conduction AND accessory pathway (e.g. WPW)
- Atrial fibrillation + hyperkalemia
- Polymorphic ventricular tachycardia
^Fixed or rate-related
Evaluation
ECG
Changes NOT always predictable and sequential
- 6.5 - 7.5 mEq/L: peaked T waves, prolonged PR interval, shortened QT interval
- 7.5 - 8.0 mEq/L: widened QRS interval, flattened P waves
- 10 - 12 mEq/L: sine wave, ventricular fibrillation, heart block
Management
Stabilize cardiac membranes
Indicated if there are any ECG changes or evidence of arrhythmias. Consider if K >7 mEq/L
- Either one of the following:
- Calcium gluconate: Give 10ml of a 10% solution over 10 mins
- Only 1/3 the calcium compared to calcium chloride
- Can cause hypotension due to osmotic shift
- Calcium chloride 1 gram IV
- Give over 1 - 2 minutes
- Extravasation is bad: use a good IV
- Usually given in code situations
- Calcium gluconate: Give 10ml of a 10% solution over 10 mins
- Takes effect in 15-30 minutes[1]
- (If given for hyperkalemic cardiac arrest, need to continue resuscitation for at least 30 minutes)
- Duration of action: 30 - 60 minutes [2]
- Use caution in patients taking Digoxin although risk of Stone heart may be unsubstantiated [3]
- Do serial ECGs to track progress: may need to give multiple doses
Shift K+ intracellularly
- Intravenous insulin + dextrose
- Give 10 units regular insulin intravenously with 25 to 50 grams (1 - 2 50 mL ampules) of 50% dextrose (D50)
- May withhold dextrose if blood sugar >300mg/dl (>17 mmol/L)
- Duration of effect: 4 - 6 hours
- Consider mixing in 10 cc NS syringe to ensure small volume of 10 units insulin fully administered via IV
- Insulin cleared renally, be careful about inducing hypoglycemia (ESRD patients).
- In a small 2017 retrospective cohort study, researchers found that giving 5 units of insulin instead of 10 units reduced serum potassium to the same extent as 10 units, with a lower rate of hypoglycemia.
- Consider decreasing to 5 units or increasing dextrose dose to 50g with following risk factors: pretreatment blood glucose <150, acute kidney injury/chronic kidney disease, no history of DM, weight <60kg, female sex [4]
- Give 10 units regular insulin intravenously with 25 to 50 grams (1 - 2 50 mL ampules) of 50% dextrose (D50)
- Nebulized albuterol 15 - 20mg
- Response is dose-dependent
- Peak effect: 30 minutes
- Duration of effect: 2 hours
- Intravenous sodium bicarbonate 50ml of 8.4% solution (1 ampoule) given over 5 minutes
- Duration of effect: 1 - 2 hours
- Generally not required, unless pH <7.1
Remove K+ from body
- Intravenous furosemide (Lasix) 40 - 80mg
- Ensure adequate urine output first
- Sodium polystyrene sulfonate (Kayexalate): 30 gm oral or per rectum
- Very Controversial, High Risk of Bowel Perforation, see: EBQ: Use of Kayexylate in Hyperkalemia
- Sodium zirconium cyclosilicate
- Potassium binder, similar to Kayexalate
- Intravenous lactated ringers solution for volume expansion if dehydrated, rhabdomyolysis, diabetic ketoacidosis or other acidosis (avoid NS, causes hyperchloremic acidosis which shifts potassium out of cells increasing level)
- consider isotonic bicarbonate if significant acidosis (D5W with 3 amps of bicarb per liter), can calculate bicarbonate deficit then divide by 150mEq/L to estimate number of liters of isotonic bicarbonate required) [5]
- Hydrocortisone if suspicious for adrenal insufficiency
- Definitive treatment is hemodialysis
Disposition
- Consideration for ICU for frequent electrolyte checks and close cardiac monitoring
See Also
External Links
References
- ↑ http://lifeinthefastlane.com/hyperkalemia/. Accessed 02/22/2016
- ↑ The Effect of Calcium on Severe Hyperkalemia http://hqmeded-ecg.blogspot.com/2015/04/the-effect-of-calcium-on-severe.html
- ↑ Erickson CP, Olson KR. Case files of the medical toxicology fellowship of the California poison control system-San Francisco: calcium plus digoxin-more taboo than toxic? J Med Toxicol. 2008 Mar;4(1):33-9
- ↑ Moussavi K1, Fitter S2, Gabrielson SW3, Koyfman A4, Long B5. Management of Hyperkalemia With Insulin and Glucose: Pearls for the Emergency Clinician. J Emerg Med. 2019 Jul;57(1):36-42.
- ↑ https://emcrit.org/pulmcrit/fluid-selection-using-ph-guided-resuscitation